Page results
-
Hypopharyngeal cancer is a rare type of cancer that affects the inlet to the oesophagus (gullet).
-
We work together closely to support and improve the health of people with type 1 and type 2 diabetes via education, training, research and through other services that we provide. Our team works in close collaboration with ophthalmologists, vascular surgeons, endocrine surgeons, obstetricians and paediatricians.
-
Dr Lynch is a consultant neurologist at the National Hospital for Neurology and Neurosurgery. He sees patients with all types of neurological disease in his general neurology clinics, and he has a particular interest in patients with inherited disorders of white matter, also called leukodystrophies
-
Information about incentive spirometry (IS) for adults with sickle cell disorder.
-
Information on exercise following your urogynaecological surgery
-
Alternatives to Accident and Emergency (A&E) and attending the Emergency Department (Casualty) at UCLH
-
Our Proton Beam Therapy (PBT) department can treat up to 650 NHS patients per year from across the south of the UK when we are at full capacity. We provide treatment for a wide range of child and teenage cancers and complex adult cancers.
-
This page provides information for patients planning or considering a homebirth with UCLH.
-
First Seizure Clinic patient information leaflet
-
The Children’s cancer appeal is raising funds to transform the radiotherapy unit at UCLH for the thousands of young patients who receive treatment each year.
File results
-
FOI/2022/0147 - Oesophageal and gastric cancer drug treatments
-
FOI/2022/0148 - Maternity related overseas services
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0151 - Omnipod patch pump
-
FOI/2022/0153 - Central water treatment equipment for renal dialysis
-
FOI/2022/0154 - Immunoglobulin treatments (for any disease)
-
FOI/2022/0155 - Patient hospital bedside and electronic patient notes
-
FOI/2022/0161 - Referral to treatment waiting times
-
FOI/2022/0167 - Prostate cancer drug treatments
-
FOI/2022/0168 - Geographic locations of patients